Download full-text PDF |
Source |
---|
Ann Pathol
December 2024
Service d'anatomie et cytologie pathologique, hôpital Pontchaillou, CHU de Rennes, université de Rennes 1, 2, rue Henri-Le-Guilloux, 35033 Rennes cedex, France; Équipe IMPACT, laboratoire traitement du signal et de l'image (LTSI) Inserm, hôpital Pontchaillou, CHU de Rennes, université Rennes 1, 35033 Rennes, France.
The 2030 French Innovation Healthcare national plan defined "Digital Healthcare" as one of its priority. The deployment of digital pathology and artificial intelligence fits perfectly into this framework. Therefore we evaluated the pathologist's interest in those fields by conducting an online survey among members of the French Society of Pathology, mainly composed of senior pathologists and trainees (n=2301).
View Article and Find Full Text PDFEnviron Res
December 2024
Institut de recherche en santé, environnement et travail (Irset), Univ Rennes, Inserm, EHESP, 9 Av. Professeur Léon Bernard, Rennes, France. Electronic address:
Introduction: While a number of studies have examined the effects of prenatal exposure to per- and polyfluoroalkyl substances (PFAS) on childhood obesity, the results reported have been inconsistent and few studies have integrated biological markers. The aim of this study was to investigate the associations between prenatal exposure to PFAS and cardiometabolic health parameters at age 12, taking pubertal stage into consideration.
Method: This study included 394 mother-child pairs enrolled in the PELAGIE mother-child cohort (France).
Soins
December 2024
CAPPS Bretagne, 2 rue Henri-le-Guilloux, 35 000 Rennes, France.
Partnership in healthcare is a cooperative relationship based on complementary knowledge between patients and professionals, which fosters the self-determination of the former. This article draws on the framework of the Montreal model applied to primary care, as well as the results of a research project that identified the key success factors for integrating patient partners into a multi-professional nursing home.
View Article and Find Full Text PDFBr J Dermatol
November 2024
Service d'onco-dermatologie, Hôpital Saint Louis APHP, 1 avenue Claude Vellefaux, 75010 Paris.
Background: The Checkmate 067 randomized controlled trial, published in 2015, demonstrated improved progression-free survival and numerically, although not statistically, superior overall survival for ipilimumab + nivolumab. The objective of this study was to compare the efficacy and safety of nivolumab to ipilimumab + nivolumab as first-line treatment for metastatic melanoma in a real-world setting.
Methods: Patients were prospectively included in the French Melbase cohort from 2013 to 2022.
Cancer Radiother
December 2024
Academic Department of Radiation Oncology, centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59000 Lille, France; Centre de recherche en informatique, signal et automatique de Lille, Cristal UMR 9189, université de Lille, Lille, France. Electronic address:
Purpose: Trimodal therapy, an organ-sparing alternative, may be proposed for selected patients with muscle-invasive bladder cancer instead of radical cystectomy. In this multicentre retrospective study, we aimed to assess the oncological outcomes of patients who had trimodal therapy for a muscle-invasive bladder cancer.
Materials And Methods: Seventy-three patients from four centres treated who had trimodal therapy (maximal transurethral resection of bladder tumour and concomitant chemoradiotherapy) for localized muscle-invasive bladder cancer were included.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!